Skip to content
  • Contacts
  • facebook
  • twitter
  • linkedin
registration | login

News and Events

The official online journal of the International Conference
on Thrombosis and Hemostasis Issues in Cancer
WEBINAR: Challenges in the management of fragile CAT patients (older patient population & palliative care) by ICTHIC Editorial Office 9 March 2023
Abstract submission deadline for ESMO Breast Cancer Congress by ICTHIC Editorial Office 15 February 2023
Abstract submission now open for ESMO 2023 by ICTHIC Editorial Office 15 February 2023
31th Congress of the International Society on Thrombosis and Haemostasis by ICTHIC Editorial Office 9 February 2023
  • Home
  • Thrombosis and cancer
    • Epidemiology
    • Basic Mechanisms
    • Prevention
    • Trials and Therapy
    • Focus on: Atrial fibrillation
    • Focus on: Pediatrics
    • Focus on: COVID-19
  • Guidelines and Tools
  • Congress reports
    • ICTHIC 2022
    • ICTHIC 2021
    • ISTH 2020
    • ASH 2020
    • ASH 2019
    • ISTH 2019
    • ICTHIC 2018
    • ESC 2018
  • News and Events
  • Past webinars
  • About
  • Contacts
  • Editorial Board
  • Most Read
  • Podcast and videos
  • Archive
  • PARTNERSHIP
Webinar

Home › Thrombosis and cancer › Prevention

Prevention

Risk factors for recurrence and major bleeding in cancer-associated thrombosis: a sub-analysis of the Caravaggio study

Patients with cancer have a high risk of recurrent venous thromboembolism (VTE) and major bleeding, which greatly...
Author ICTHIC Editorial OfficePosted on 23 February 2023

How does clinical thrombosis presentation affect illness perception in patients with cancer-associated thrombosis?

Although thrombosis is the second cause of death in patients with cancer, after cancer itself, most of these patients...
Author ICTHIC Editorial OfficePosted on 14 February 2023

Summary ESMO Clinical Practice Guideline for the management of venous thromboembolism in cancer patients

Venous thromboembolism (VTE) is the second cause of death in people with cancer, after cancer itself. Cancer and VTE...
Author ICTHIC Editorial OfficeAuthor Anna FalangaPosted on 15 January 202314 February 2023

DEBATE: Should VTE treatment continue beyond six months? The evidence behind the decision to continue anticoagulation

During the 11th ICTHIC, Agnes YY Lee and Marcello Di Nisio debated whether anticoagulation treatment should be...
Author ICTHIC Editorial OfficePosted on 21 August 202223 August 2022

DEBATE: Should VTE treatment continue beyond 6 months? Evidence supporting anticoagulation discontinuation

During the 11th ICTHIC, Agnes YY Lee and Marcello Di Nisio debated whether anticoagulation treatment should be...
Author ICTHIC Editorial OfficePosted on 10 August 202223 August 2022

Venus thromboembolism and risk stratification and hematological malignancies

In recent years, the incidence of venous thromboembolism (VTE) has been rising in patients with cancer. A Danish cohort...
Author ICTHIC Editorial OfficePosted on 28 June 20221 July 2022

Diagnosis, screening, and prevention of cancer-associated thrombosis

The tight association between malignancies and hypercoagulation was highlighted almost a century ago by the...
Author ICTHIC Editorial OfficePosted on 24 June 2022

PODCAST. Building a CAT Clinic: Real-World Systems Approaches to Prevention and Treatment. Waiting for ICTHIC 2022

Cancer-associated thrombosis (CAT) is an important and increasingly common complication of cancer and cancer...
Author ICTHIC Editorial OfficeAuthor Alok KhoranaPosted on 14 June 202229 September 2022

How to improve patient’s awareness about the risk of cancer-associated thrombosis

Although patients with cancer have a four-to-five-fold increased risk of venous thromboembolism (VTE) compared with the...
Author ICTHIC Editorial OfficePosted on 16 May 202225 May 2022

Prognostic markers in patients with advanced cancer. Waiting for ICTHIC 2022

Estimation of prognosis is of utmost importance when managing patients with advanced cancer: it helps make decisions...
Author ICTHIC Editorial OfficePosted on 23 December 202113 January 2022

Posts navigation

Page 1 Page 2 Next page

ICTHIC magazine is supported by the unrestricted educational grant from

SUBSCRIBE TO OUR NEWSLETTER

I agree to receive updates concerning the content published in ICTHIC MAGAZINE and related promotional content/activities (more details)

logo polistudium
Scientific and Web contents by Polistudium s.r.l.
Via Anfossi 36, 20135 Milan, Italy
info@polistudium.it
None of the information published on the ICTHC magazine website, in particular, information related to the choice and use of drugs, replaces the advice of a doctor
© COPYRIGHT 2019 ICTHIC Magazine
Privacy policy
None of the information published on the ICTHC magazine website, in particular, information related to the choice and use of drugs, replaces the advice of a doctor.

Accept to continue
By registering to the newsletter, the User’s email address will be added to the contact list of ICTHIC Magazine, in order to receive email messages concerning the content published in ICTHIC Magazine and related promotional content/activities. Your email address may also be added to this list as a result of signing up to this Website. Personal Data collected: email address, first name, last name, profession.
ICTHIC CONFERENCE Newsletter By registering to the newsletter, the User’s email address will be added to the contact list of ICTHIC, in order to receive newsletters concerning the conference, such as Save the date, information about the meeting venue, the publication of the program, registration fees and deadline, abstract submission deadline and oral communication/poster instructions, hotel booking availability and deadline, social program for accompanying persons, the publication of speakers slides, photo/videogallery of the last edition and information about future editions of the conference. Your email address may also be added to this list as a result of signing up to this Website.